Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,286,856 papers from all fields of science
Search
Sign In
Create Free Account
BRCA3 gene
Known as:
Breast Cancer 3 Gene
, BRCA3
, breast cancer 3
Expand
This gene plays a role in tumor suppression.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
8 relations
BRCA3 Protein
BRCA3 wt Allele
BREAST CANCER 3
Breast Carcinoma
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
BRCA1/2-negative, high-risk breast cancers (BRCAX) for Asian women: genetic susceptibility loci and their potential impacts
Jooyeon Lee
,
Jisun Kim
,
+11 authors
J. Sung
Scientific Reports
2018
Corpus ID: 53039940
“BRCAX” refers breast cancers occurring in women with a family history predictive of being a BRCA1/2 mutation carrier, but BRCA1…
Expand
2015
2015
Detection of novel germline mutations for breast cancer in non‐BRCA1/2 families
Fatima Aloraifi
,
T. Mcdevitt
,
+10 authors
A. Bracken
The FEBS Journal
2015
Corpus ID: 35658960
The identification of the breast cancer susceptibility genes BRCA1 and BRCA2 enhanced clinicians' ability to select high‐risk…
Expand
Review
2013
Review
2013
Risk of Pancreatic Cancer in Breast Cancer Families from the Breast Cancer Family Registry
E. Mocci
,
R. Milne
,
+8 authors
D. Goldgar
Cancer Epidemiology, Biomarkers and Prevention
2013
Corpus ID: 21827229
Background: Increased risk of pancreatic cancer has been reported in breast cancer families carrying BRCA1and BRCA2 mutations…
Expand
2012
2012
MUTYH gene variants and breast cancer in a Dutch case–control study
A. A. Out
,
Marijke Wasielewski
,
+11 authors
P. Devilee
Breast Cancer Research and Treatment
2012
Corpus ID: 6499674
The MUTYH gene is involved in base excision repair. MUTYH mutations predispose to recessively inherited colorectal polyposis and…
Expand
Highly Cited
2008
Highly Cited
2008
Promoter methylation-associated loss of ID4 expression is a marker of tumour recurrence in human breast cancer
E. Noetzel
,
J. Veeck
,
+5 authors
E. Dahl
BMC Cancer
2008
Corpus ID: 1783781
BackgroundInhibitor of DNA binding/Inhibitor of differentiation 4 (ID4) is a critical factor for cell proliferation and…
Expand
Highly Cited
2007
Highly Cited
2007
Immunohistochemical classification of non-BRCA1/2 tumors identifies different groups that demonstrate the heterogeneity of BRCAX families
E. Honrado
,
A. Osorio
,
+10 authors
J. Benítez
Modern Pathology
2007
Corpus ID: 6693292
Around 25% of hereditary breast and ovarian cancer families have mutations in the BRCA1 and BRCA2 genes. The search for other…
Expand
2005
2005
Comparison of genomic abnormalities between BRCAX and sporadic breast cancers studied by comparative genomic hybridization
J. Gronwald
,
A. Jauch
,
+10 authors
J. Lubiński
International Journal of Cancer
2005
Corpus ID: 43100894
Very little is known about the chromosomal regions harbouring genes involved in initiation and progression of BRCAX‐associated…
Expand
Highly Cited
2002
Highly Cited
2002
Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium
Deborah J. Thompson
,
C. Szabo
,
+46 authors
M. Stratton
Proceedings of the National Academy of Sciences…
2002
Corpus ID: 23269378
The known susceptibility genes for breast cancer, including BRCA1 and BRCA2, only account for a minority of the familial…
Expand
Highly Cited
2001
Highly Cited
2001
Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population‐based study
A. Antoniou
,
P. Pharoah
,
Greg McMullan
,
Nickolas E. Day
,
B. Ponder
,
D. Easton
Genetic Epidemiology
2001
Corpus ID: 36209899
We used data from a population based series of breast cancer patients to investigate the genetic models that can best explain…
Expand
Review
2000
Review
2000
Founder populations and their uses for breast cancer genetics
S. Neuhausen
Breast Cancer Research
2000
Corpus ID: 2187901
Numerous founder mutations have been reported in BRCA1 and BRCA2. For genetic screening of a population with a founder mutation…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE